Graph Database :: Data Schema

Graph Database :: Data Schema

×
Entries: LiteratureReference
Identifier Name
1299311 Potassium channel silencing by constitutive endocytosis and intracellular sequestration
1296210 Potassium channels: newly found players in synaptic plasticity
180308 Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites
9674255 Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib)
9833838 Potential role for snoRNAs in PKR activation during metabolic stress
1458568 Potential role of Rab4 in the regulation of subcellular localization of Glut4 in adipocytes
1454667 Potential role of TBC1D4 in enhanced post-exercise insulin action in human skeletal muscle
2460103 Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis
9694202 Potential roles of PP2A-Rac1 signaling axis in pancreatic β-cell dysfunction under metabolic stress: Progress and Promise
2130364 Potential sites for processing of the human invariant chain by cathepsins D and E
5096504 Potential targets for HSF1 within the preinitiation complex
8984151 Potentiation of RNA polymerase II transcription by Gal4-VP16 during but not after DNA replication and chromatin assembly
9697462 Practitioner review: early adversity and developmental disorders
9696382 Pragmin, a novel effector of Rnd2 GTPase, stimulates RhoA activity
9709154 Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma
9733278 Pramlintide in the treatment of diabetes mellitus
9617396 Prazosin in the treatment of hypertension
5634801 Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity
913222 Prdm9 controls activation of mammalian recombination hotspots
1368954 Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis
9021429 Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression
9015723 Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma
9750110 Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine
72166 Pre-mRNA splicing: the discovery of a new spliceosome doubles the challenge.
1266696 Pre-pro-B cell growth-stimulating factor (PPBSF) upregulates IL-7Ralpha chain expression and enables pro-B cells to respond to monomeric IL-7
5637613 Pre-steady-state fluorescence analysis of damaged DNA transfer from human DNA glycosylases to AP endonuclease APE1
873818 Preassembly and ligand-induced restructuring of the chains of the IFN-gamma receptor complex: the roles of Jak kinases, Stat1 and the receptor chains
8855957 Precipitin reaction between Sda-active human Tamm-Horsfall glycoprotein and anti-Sda-serum
83611 Precise binding of single-stranded DNA termini by human RAD52 protein.
163295 Precise identification of individual promoters for transcription of each strand of human mitochondrial DNA
2453754 Precise mapping of an IGF-I-binding site on the IGF-1R
3247704 Precise regulation of porcupine activity is required for physiological Wnt signaling
9629074 Precise timing of ATPase activation drives targeting of tail-anchored proteins
9756000 Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression
9681746 Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases
9674258 Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment
9755171 Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models
9754230 Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
9678571 Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
9755986 Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors
2077415 Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma
9699354 Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor
8865218 Precursor convertases in the secretory pathway, cytosol and extracellular milieu
9833736 Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity
1254367 Precursor oxidation by Mia40 and Erv1 promotes vectorial transport of proteins into the mitochondrial intermembrane space
75337 Precursor structure, expression, and tissue distribution of human guanylin.
2318448 Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features
9793513 Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system
9631243 Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A
9624765 Predicting the targeting of tail-anchored proteins to subcellular compartments in mammalian cells
353639 Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris
9699355 Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemia
8850684 Prediction of structural domains of TAP reveals details of its interaction with p15 and nucleoporins
1168411 Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7
1112529 Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation
Cite Us!